In vitro hepatic trans-differentiation of human mesenchymal stem cells using sera from congestive/ischemic liver during cardiac failure

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Bishi, Dillip Kumar ^a,b   Mathapati, Santosh ^a,b   Cherian, Kotturathu Mammen ^b   Guhathakurta, Soma ^a   Verma, Rama Shanker ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b International Centre for Cardio Thoracic and Vascular Diseases   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; CYTOCHROME P450; GLYCOGEN; HEMOGLOBIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; SCATTER FACTOR; TRANSCRIPTION FACTOR SNAIL; UREA; UVOMORULIN; BIOLOGICAL MARKER; CADHERIN; CDH1 PROTEIN, HUMAN; CULTURE MEDIUM; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; AFP GENE; ALB GENE; ARTICLE; BILIRUBIN BLOOD LEVEL; CDH 1 GENE; CELL COUNT; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CY 18 GENE; CYTOTOXICITY; ENZYME BLOOD LEVEL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HNF 4ALPHA GENE; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; IN VITRO STUDY; LIVER CONGESTION; LIVER ISCHEMIA; MALE; MESENCHYMAL STEM CELL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SNAIL GENE; UREA BLOOD LEVEL; BLOOD; CELL SHAPE; CULTURE MEDIUM; CULTURE TECHNIQUE; GENETICS; HEPG2 CELL LINE; ISCHEMIA; LIVER; LIVER CELL; LIVER REGENERATION; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SERUM; VASCULARIZATION;

ADULT; BIOLOGICAL MARKERS; CADHERINS; CELL CULTURE TECHNIQUES; CELL SHAPE; CELL TRANSDIFFERENTIATION; CULTURE MEDIA; FEMALE; GENE EXPRESSION; HEART FAILURE; HEP G2 CELLS; HEPATOCYTES; HUMANS; ISCHEMIA; LIVER; LIVER REGENERATION; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; SERUM; TRANSCRIPTION FACTORS;

EID: 84898668123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092397     Document Type: Article

References (57)

1. Williams R (2006) Global challenges (Pubitemid 44433707)
2. van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, et al. (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16: 84-90.
3. Maleki M, Vakilian F, Amin A (2011) Liver diseases in heart failure. Heart Asia 3: 143-149.
4. Lau GT, Tan HC, Kritharides L (2002) Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90: 1405-1409. (Pubitemid 35449493)
5. Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis 6: 947-967. (Pubitemid 36026457)
6. Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371: 838-851. (Pubitemid 351323895)
7. Gallegos-Orozco JF, Vargas HE (2009) Liver transplantation: from child to MELD. Med Clin North Am 93: 931-950.
8. Dalgetty DM, Medine CN, Iredale JP, Hay DC (2009) Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol 297: G241-G248.
9. Zhao Q, Ren H, Zhu D, Han Z (2009) Stem/progenitor cells in liver injury repair and regeneration. Biol Cell 101: 557-571.
10. Zhao Y, Xu Y, Zhang B, Wu X, Xu F, et al. (2010) In vivo generation of thick, vascularized hepatic tissue from collagen hydrogel-based hepatic units. Tissue Eng Part C Methods 16: 653-659.
11. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, et al. (2006) Isolation and Characterization of a Stem Cell Population from Adult Human Liver. Stem Cells 24: 2840-2850. (Pubitemid 46053020)
12. Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M, et al. (2003) Potential of embryonic and adult stem cells in vitro. Biol Chem 384: 1391-1409. (Pubitemid 37508643)
13. Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, et al. (2010) Induced pluripotent stem cells: A new era for hepatology. J Hepatol 53: 738-751.
14. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, et al. (1999) Bone marrow as a potential source of hepatic oval cells. Science 284: 1168-1170. (Pubitemid 29288406)
15. Houlihan DD, Newsome PN (2008) Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 135: 438-450.
16. Gilchrist ES, Plevris JN (2010) Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl 16: 118-129.
17. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, et al. (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24: 2292-2298. (Pubitemid 44527483)
18. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, et al. (2007) Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 10: 459-466. (Pubitemid 350001896)
19. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, et al. (2009) Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 21: 1199-1205.
20. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, et al. (2002) Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109: 1291-1302. (Pubitemid 34546893)
21. Lee KD, Kuo TKC, Whang-Peng J, Chung YF, Lin CT, et al. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284. (Pubitemid 39657001)
22. Snykers S, Vanhaecke T, Papeleu P, Luttun A, Jiang Y, et al. (2006) Sequential exposure to cytokines reflecting embryogenesis: The key for in vitro differentiation of adult bone marrow stem cells into functional hepatocyte-like cells. Toxicol Sci 94: 330-341. (Pubitemid 44817149)
23. Wang PP, Wang JH, Yan ZP, Hu MY, Lau GK, et al. (2004) Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun 320: 712-716. (Pubitemid 38887201)
24. Avital I, Inderbitzin D, Aoki T, Tyan DB, Cohen AH, et al. (2001) Isolation, Characterization, and Transplantation of Bone Marrow-Derived Hepatocyte Stem Cells. Biochem Biophys Res Commun 288: 156-164. (Pubitemid 32999740)
25. Yamazaki S, Miki K, Hasegawa K, Sata M, Takayama T, et al. (2003) Sera from liver failure patients and a demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol 39: 17-23. (Pubitemid 36724103)
26. Cai YF, Zhen ZJ, Min J, Fang TL, Chu ZH, et al. (2004) Selection, proliferation and differentiation of bone marrow-derived liver stem cells with a culture system containing cholestatic serum in vitro. World J Gastroenterol 10: 3308-3312. (Pubitemid 39585471)
27. Xu J, Deng X, Demetriou AA, Farkas DL, Hui T, et al. (2008) Factors released from cholestatic rat livers possibly involved in inducing bone marrow hepatic stem cell priming. Stem Cells Dev 17: 143-155. (Pubitemid 351271613)
28. Yang Y, Qu B, Huo JH, Wu SL, Zhang MY, et al. (2009) Serum from radiofrequency-injured livers induces differentiation of bone marrow stem cells into hepatocyte-like cells. J Surg Res 155: 18-24.
29. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T (1995) Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 21: 106-112.
30. Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, et al. (2002) Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer 95: 824-834. (Pubitemid 34839675)
31. Matsumori A, Furukawa Y, Hashimoto T, Ono K, Shioi T, et al. (1996) Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221: 391-395. (Pubitemid 26136482)
32. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, et al. (1996) A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 28: 409-413. (Pubitemid 26296043)
33. Zhu Y, Hojo Y, Ikeda U, Shimada K (2000) Production of hepatocyte growth factor during acute myocardial infarction. Heart 83: 450-455. (Pubitemid 30316765)
34. Ueno S, Ikeda U, Hojo Y, Arakawa H, Nonaka M, et al. (2001) Serum hepatocyte growth factor levels are increased in patients with congestive heart failure. J Card Fail 7: 329-334. (Pubitemid 34008164)
35. Rickham PP (1964) Human experimentation. Code of ethics of the world medical association. Declaration of helsinki. Br Med J 2: 177.
36. Chang CY, Schiano TD (2007) Drug hepatotoxicity. Aliment Pharmacol Ther 25: 1135-1151.
37. Snykers S, De Kock J, Tamara V, Rogiers V (2011) Hepatic differentiation of mesenchymal stem cells: in vitro strategies. Methods Mol Biol 698:305-314.
38. Ríus C, Smith JD, Almendro N, Langa C, Botella LM, et al. (1998) Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood 92: 4677-4690. (Pubitemid 29005870)
39. Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, et al. (2012) Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest 42: 153-163.
40. Allen LA, Felker GM, Pocock S, McMurray JJV, Pfeffer MA, et al. (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11: 170-177.
41. Szygula-Jurkiewicz B, Wojnicz R, Lekston A, Duszanska A, Spinczyk B, et al. (2007) Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension. Pol Arch Med Wewn 117: 227-233. (Pubitemid 47508036)
42. Sherlock S (1951) The liver in heart failure; relation of anatomical, functional, and circulatory changes. Br Heart J 13: 273-293.
43. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, et al. (2006) Association between the UGT1A1*28 allele, bilirubin Levels, and coronary heart disease in the Framingham heart study. Circulation 114: 1476-1481. (Pubitemid 44527002)
44. Stocker R (2004) Antioxidant activities of bile pigments. Antioxid Redox Signal 6: 841-849. (Pubitemid 39237937)
45. Ueno S, Tanabe G, Kawaida K, Hamanoue M, Mitsue S, et al. (1997) Serum hepatocyte growth factor (HGF) levels predict the outcomes in hepatectomized patients with postoperative hyperbilirubinemia. Int Hepatol Commun 6: 294-299. (Pubitemid 27192039)
46. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, et al. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443. (Pubitemid 19277521)
47. Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, et al. (2005) Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 150: 137-143. (Pubitemid 41097441)
48. Rychli K, Richter B, Hohensinner PJ, Mahdy Ali K, Neuhold S, et al. (2011) Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure. Heart 97: 1158-1163.
49. Funakoshi H, Nakamura T (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327: 1-23. (Pubitemid 35447813)
50. Min J, Shang CZ, Chen YJ, Zhang L, Liu L, et al. (2007) Selective enrichment of hepatocytes from mouse embryonic stem cells with a culture system containing cholestatic serum. Acta Pharmacol Sin 28: 1931-1937. (Pubitemid 350198351)
51. Li Z, Mizuno S, Nakamura T (2007) Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am J Physiol Gastrointest Liver Physiol 292: G639-G646.
52. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, et al. (1995) Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95: 2581-2586.
53. Ruiz-Gaspà S, Martinez-Ferrer A, Guañbens N, Dubreuil M, Peris P, et al. (2011) Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseases. Hepatology 54: 2104-2113.
54. Ong SY, Dai H, Leong KW (2006) Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng 12: 3477-3485. (Pubitemid 46037170)
55. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, et al. (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51: 297-305.
56. Ochiya T, Yamamoto Y, Banas A (2010) Commitment of stem cells into functional hepatocytes. Differentiation 79: 65-73.
57. Sivasubramaniyan K, Atluri RR, Sarda K, Arvind M, Balaji V et al. (2008) Endotoxin-induced silencing of mesoderm induction and functional differentiation: role of HMGB1 in pluripotency and infection. Regen Med 3:23-31. (Pubitemid 351551648)